Olympus Announces Market Launch of EVIS X1 Endoscopy System

Olympus Corporation, a global medical technology company committed to making people’s lives healthier, safer and more fulfilling, announced today the market launch of its next-generation EVIS X1™ endoscopy system, which will be on display and demonstrated Oct. 22-24 during the American College of Gastroenterology (ACG) annual meeting in Vancouver, Canada.

Richard Reynolds, President of the Medical Systems Group for Olympus America, Inc.

“Olympus is thrilled to bring our most advanced endoscopy system to GI practitioners in the U.S. The remarkable new technologies for visualizing the GI tract are designed to help physicians see more and do more to help their patients.”

The EVIS X1 endoscopy system received clearance earlier this year along with two compatible endoscopes: the GIF-1100 gastrointestinal videoscope indicated for use within the upper digestive tract and the CF-HQ1100DL/I colonovideoscope indicated for use within the lower digestive tract. The ErgoGrip control section of these endoscopes is 10% lighter than Olympus’ previous generation, and they are designed to increase user comfort and scope handling and to accommodate users with small hands.1

Features of the EVIS X1™ endoscopy system include:

  • Texture and Color Enhancement Imaging (TXI™) technology is designed to increase the visibility of lesions and polyps by enhancing image color and texture during endoscopic screening. 2
  • Red Dichromatic Imaging (RDI™) technology is designed to enhance the visibility of deep blood vessels and bleeding points.
  • Brightness Adjustment Imaging with Maintenance of Contrast (BAI-MAC™) technology is designed to correct the brightness levels in dark areas of the endoscopic image, while maintaining the brightness of lighter areas, to increase the total distance view.3
  • Narrow Band Imaging™ (NBI™) technology continues to be featured in the EVIS X1 endoscopy system. NBI technology enhances visual observation of mucosal and vascular patterns by utilizing specific blue and green wavelengths absorbed by hemoglobin.
  • Streamline procedures: The touch panel on the CV-1500 video system center allows the user to initiate all procedures and settings and control image data from one device.4
  • MyCV mode: MyCV mode allows a physician to personalize imaging configurations and turn multiple functions off and on with a single scope button.

TXI, RDI, BAI-MAC and NBI technologies are not intended to replace histopathological sampling as a means of diagnosis. These are adjunctive tools for endoscopic examination that can be used to supplement Olympus white light imaging.

Olympus® GI endoscopy systems are used by physicians to help them to diagnose, treat, and observe diseases and disorders of the upper and lower GI tract such as acid reflux, ulcers, Crohn’s disease, Celiac disease, and colorectal cancer (CRC). An endoscope is commonly used during a screening colonoscopy, when a gastroenterologist examines the lining of the colon and may remove any potentially cancerous growths, known as polyps. The addition of new imaging technologies in the EVIS X1 endoscopy system may help physicians to visualize these abnormalities.

CRC represents the third most common cancer diagnosis for men and women with an estimated 153,000 cases diagnosed annually, according to the American Cancer Society.5 CRC is a preventable and treatable disease, however, with a 5-year survival rate of up to 91%, if caught at a localized stage.6

For more information, visit the EVIS X1 endoscopy system page. For a demonstration, visit the Olympus booth #911 at ACG. Live demonstrations of the new imaging technologies will be offered during ACG 5 p.m. Oct. 22 and 11 a.m. Oct. 23-24. Visit the Olympus website for information on the entire gastroenterology portfolio.

As a leading medical technology company, Olympus uses innovative capabilities in medical technology, therapeutic intervention, and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic, and minimally invasive procedures to improve clinical outcomes, reduce overall costs, and enhance the quality of life for patients. Olympus’ portfolio includes endoscopes, laparoscopes, and video imaging systems, as well as surgical energy devices, system integration solutions, medical services, and a wide range of endotherapy instruments. For more information, visit medical.olympusamerica.com.

1 Data on file with Olympus (DC00482729, DC00600786, DC00031984, DC00482747, DC00482867, DC00600794, DC00481878, DC00031984 and DC00841888).
2 Data on file with Olympus (D00489968).
3 Data on file with Olympus (DC00436067).
4 Data on file with Olympus (DC00460933).
5 American Cancer Society, “Key Statistics for Colorectal Cancer.” Rev. January 2023.
6 American Cancer Society, “Survival Rates for Colorectal Cancer.” Rev. March 2023.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

"Our partnership with UCB highlights the potential of leveraging AI for improving care for many diseases, including osteoporosis" explains Richard Ljuhar, CEO at ImageBiopsy Lab.
Philips and Vanderbilt assessed 13 diagnostic imaging devices including MR, CT, ultrasound and X-ray, which account for an estimated 12,000 patient scans per month and found that, over a period of 10 years, they emit the CO₂ equivalent of approximately 1,000 gas cars driven for one year.
Advanced molecular imaging, magnetic resonance, computed tomography and digital radiography technologies from market leader United Imaging Healthcare are breaking new ground in medicine and helping to improve the quality of patient care around the world.
According to Stephen K. Hu, LG Business Solutions USA’s head of medical displays, RSNA attendees who visit LG’s booth #1361 can see how its wide variety of medical displays increase flexibility and choice while delivering leading performance and capabilities for various medical settings.
Apollo eBook introduces a paradigm shift in enterprise imaging, explaining how a multidisciplinary, patient-centric approach ensures improved patient outcomes, thinking beyond the radiology workflow to reflect both the workflows of other specialties and medical encounters.

By using this website you agree to accept Medical Device News Magazine Privacy Policy